ATE232729T1 - Behandlung von n. opticus-beschwerden mit einem prostansäurederivat - Google Patents
Behandlung von n. opticus-beschwerden mit einem prostansäurederivatInfo
- Publication number
- ATE232729T1 ATE232729T1 AT96301637T AT96301637T ATE232729T1 AT E232729 T1 ATE232729 T1 AT E232729T1 AT 96301637 T AT96301637 T AT 96301637T AT 96301637 T AT96301637 T AT 96301637T AT E232729 T1 ATE232729 T1 AT E232729T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- prostone
- opticus
- discomforts
- acid derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5103195 | 1995-03-10 | ||
JP17895495 | 1995-07-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE232729T1 true ATE232729T1 (de) | 2003-03-15 |
Family
ID=26391550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96301637T ATE232729T1 (de) | 1995-03-10 | 1996-03-11 | Behandlung von n. opticus-beschwerden mit einem prostansäurederivat |
Country Status (12)
Country | Link |
---|---|
US (1) | US5773471A (de) |
EP (1) | EP0730866B1 (de) |
KR (1) | KR100399795B1 (de) |
CN (1) | CN1106844C (de) |
AT (1) | ATE232729T1 (de) |
AU (1) | AU701620B2 (de) |
CA (1) | CA2171226C (de) |
DE (1) | DE69626232T2 (de) |
ES (1) | ES2192599T3 (de) |
NO (1) | NO310178B1 (de) |
NZ (1) | NZ286141A (de) |
TW (1) | TW420611B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6184250B1 (en) | 1993-08-03 | 2001-02-06 | Alcon Laboratories, Inc. | Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
US6417228B1 (en) | 1998-11-02 | 2002-07-09 | Alcon Manufacturing, Ltd.. | 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension |
US6160013A (en) * | 1998-12-17 | 2000-12-12 | Alcon Laboratories, Inc. | 14-aza prostaglandins for the treatment of glaucoma and ocular hypertension |
US6211226B1 (en) | 1998-12-17 | 2001-04-03 | Alcon Laboratories, Inc. | 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension |
WO2000038667A2 (en) | 1998-12-24 | 2000-07-06 | Alcon Laboratories, Inc. | Prostaglandin e agonists for treatment of glaucoma |
TWI225398B (en) * | 1999-07-14 | 2004-12-21 | R Tech Ueno Ltd | Composition for treatment of external secretion disorders |
DE60228431D1 (de) * | 2001-03-28 | 2008-10-02 | Santen Pharmaceutical Co Ltd | Heilmittel für erkrankungen der retina und der aderhaut die als aktive bestandteile steroide enthalten |
BR0209601A (pt) * | 2001-05-14 | 2004-03-23 | Sucampo Ag | Método para o tratamento da hipertensão ocular e do glaucoma |
US20040254247A1 (en) * | 2001-07-31 | 2004-12-16 | Ryuji Ueno | Method and composition for treatnment of ocular hypertension and glaucoma |
WO2003018025A1 (en) * | 2001-08-23 | 2003-03-06 | Sucampo Ag | Method and composition for treatment of ocular hypertension and glaucoma |
WO2003020283A2 (en) * | 2001-08-29 | 2003-03-13 | Novartis Ag | Method for treating diabetic retinopathy |
US8580851B2 (en) | 2002-08-21 | 2013-11-12 | Sucampo Ag | Ophthalmic solution |
ES2431640T3 (es) | 2003-08-21 | 2013-11-27 | Sucampo Ag | Composición oftálmica que comprende éster isopropílico de unoprostona y un agente de viscosidad |
TW201410248A (zh) * | 2005-03-04 | 2014-03-16 | Sucampo Ag | 處理週邊血管疾患之方法及組成物 |
KR101396731B1 (ko) * | 2005-03-31 | 2014-05-19 | 산텐 세이야꾸 가부시키가이샤 | 프로스타글란딘 F2a 유도체를 유효 성분으로서 함유하는망막신경세포 보호제 |
WO2006112313A1 (ja) * | 2005-04-13 | 2006-10-26 | Ube Industries, Ltd. | インダゾール誘導体を有効成分として含む網膜神経細胞保護剤 |
KR20140035363A (ko) | 2011-04-07 | 2014-03-21 | 수캄포 아게 | 안정피로 치료 방법 |
RU2458702C1 (ru) * | 2011-06-30 | 2012-08-20 | Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Новокузнецский государственный институт усовершенствования врачей" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения атрофии зрительного нерва у детей раннего возраста |
AR092821A1 (es) | 2012-04-20 | 2015-05-06 | Sucampo Ag | Conjugado de derivado de acido graso-polimero |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE308135C (de) * | ||||
FR503887A (fr) * | 1918-10-17 | 1920-06-19 | Brown | Engrenages |
ES2052735T3 (es) * | 1987-09-18 | 1994-07-16 | R Tech Ueno Ltd | Un metodo para producir un agente hipotensor ocular. |
US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
EP0503887B1 (de) * | 1991-03-14 | 1996-08-28 | R-Tech Ueno Ltd. | Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen |
CA2065889C (en) * | 1991-10-02 | 2002-08-27 | Tetsuya Sugiyama | Increasing the choroidal blood flow |
-
1996
- 1996-03-05 TW TW085102651A patent/TW420611B/zh not_active IP Right Cessation
- 1996-03-08 NO NO19960974A patent/NO310178B1/no not_active IP Right Cessation
- 1996-03-08 CA CA002171226A patent/CA2171226C/en not_active Expired - Lifetime
- 1996-03-08 AU AU48003/96A patent/AU701620B2/en not_active Expired
- 1996-03-08 NZ NZ286141A patent/NZ286141A/en not_active IP Right Cessation
- 1996-03-08 US US08/613,048 patent/US5773471A/en not_active Expired - Lifetime
- 1996-03-09 CN CN96107319A patent/CN1106844C/zh not_active Expired - Lifetime
- 1996-03-09 KR KR1019960006237A patent/KR100399795B1/ko not_active IP Right Cessation
- 1996-03-11 ES ES96301637T patent/ES2192599T3/es not_active Expired - Lifetime
- 1996-03-11 EP EP96301637A patent/EP0730866B1/de not_active Expired - Lifetime
- 1996-03-11 DE DE69626232T patent/DE69626232T2/de not_active Expired - Lifetime
- 1996-03-11 AT AT96301637T patent/ATE232729T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1106844C (zh) | 2003-04-30 |
KR100399795B1 (ko) | 2003-12-31 |
EP0730866A3 (de) | 1996-12-27 |
CA2171226C (en) | 2009-12-15 |
AU4800396A (en) | 1997-01-30 |
AU701620B2 (en) | 1999-02-04 |
TW420611B (en) | 2001-02-01 |
NO960974D0 (no) | 1996-03-08 |
CN1140057A (zh) | 1997-01-15 |
DE69626232D1 (de) | 2003-03-27 |
EP0730866A2 (de) | 1996-09-11 |
US5773471A (en) | 1998-06-30 |
CA2171226A1 (en) | 1996-09-11 |
KR960033452A (ko) | 1996-10-22 |
ES2192599T3 (es) | 2003-10-16 |
NZ286141A (en) | 1999-10-28 |
NO960974L (no) | 1996-09-11 |
NO310178B1 (no) | 2001-06-05 |
EP0730866B1 (de) | 2003-02-19 |
DE69626232T2 (de) | 2003-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE232729T1 (de) | Behandlung von n. opticus-beschwerden mit einem prostansäurederivat | |
BR0307788A (pt) | método de redução e tratamento de imunossupressão induzida por uv-b | |
ATE330606T1 (de) | Verfahren zur vorbeugung von nmda-rezeptor vermittelten neuronalen schäden | |
DE69523350D1 (de) | Behandlung von hyperproliferativen Gefässerkrankungen | |
DE69632743D1 (de) | Verfahren zur regulierung des vagaltonus | |
UA27911C2 (uk) | Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну | |
ATE194081T1 (de) | Verfahren zur behandlung von verletzungen retinaler ganglione mit neurotrophischem faktor aus der glialzellinie (gdnf) | |
PT777483E (pt) | Metodos e meio para administrar farmacos | |
DK0707487T3 (da) | Fremgangsmåder og farmaceutiske præparater, der er nyttige til behandling af neurologiske lidelser | |
HRP920667A2 (en) | Application of fultripine active substance for preventing muscle deformation | |
DE3867736D1 (de) | Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels. | |
AU587054B2 (en) | Novel pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration | |
MY104521A (en) | Treatment of depression. | |
ES511132A0 (es) | "procedimiento para la preparacion de un colirio". | |
EA199800535A1 (ru) | Способ лечения боли | |
ATE167398T1 (de) | Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide | |
DE59209484D1 (de) | Verfahren zur reinigung von gebrauchten schmierölen | |
ATE72115T1 (de) | Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a- | |
DE3066521D1 (en) | Drug for the local treatment of glaucoma | |
DE3685988T2 (de) | Verwendung von "naftidrofuryl" zur behandlung von neuropathien. | |
DE3168004D1 (en) | Ophthalmic composition of 5-fluoro-2-methyl-1-(p-methylthio-benzylidene)-3-indenylacetic acid or salt thereof | |
EA200101043A1 (ru) | Способ лечения неврологических или нейропсихиатрических расстройств | |
IT8519855A0 (it) | Metodo per la cura di disturbi degli occhi, in particolare congiuntivite allergica. | |
RU95111135A (ru) | Способ лечения нисходящих атрофий зрительного нерва методом прямого электрофореза | |
IT1277102B1 (it) | Procedimento per la scissione dell'acido 6-metossi-alfa-metil-2- naftalenacetico racemico nei suoi enantiomeri |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |